Home
→
Browsing by Author

Browsing by Author "Salvatella Giralt, Neus"

Now showing items 1-5 of 5

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

Romaguera, Rafael; Salvatella Giralt, Neus; Gomez-Hospital, Joan-Antoni; SUGAR trial investigators (Oxford University Press, 2022)

Aim: patients with diabetes mellitus are at high risk of adverse events after percutaneous revascularization, with no differences in outcomes between most contemporary drug-eluting stents. The Cre8 EVO stent releases a ...
Coronary endothelium-dependent vasomotor function after drug-eluting stent and bioresorbable scaffold implantation

Gomez-Lara, Josep; Oyarzabal, Loreto; Ortega-Paz, Luis; Brugaletta, Salvatore; Romaguera, Rafael; Salvatella Giralt, Neus; Roure, Gerard; Rivero, Fernando; Fuentes, Lara; Alfonso, Fernando; Otaegui, Imanol; Vandeloo, Bert; Vaquerizo Montilla, Beatriz; Sabaté, Manel; Comín Colet, Josep; Gomez-Hospital, Joan-Antoni (Wiley, 2021)

Background Early generation drug-eluting stents (DESs) showed a high grade of coronary endothelial dysfunction that was attributed to lack of stent reendothelialization. Endothelium-dependent vasomotor response of current ...
Left atrial appendage closure with a new occluder device: efficacy, safety and mid-term performance

Llagostera Martín, Marc; Cubero Gallego, Héctor; Mas Stachurska, Aleksandra; Salvatella Giralt, Neus; Sánchez Carpintero, Andrea; Tizón-Marcos, Helena; Garcia Guimaraes, Marcos; Calvo-Fernández, Alicia; Molina Ferragut, Luis; Vaquerizo Montilla, Beatriz (MDPI, 2021)

The LAmbreTM device is a novel system designed for left atrial appendage closure (LAAC). First registries showed a high rate of device implantation success. However, few mid-term results are available. We present our 1- ...
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy.

Tarantini, Giuseppe; Nai Fovino, Luca; Tellaroli, Paola; Chieffo, Alaide; Barioli, Alberto; Menozzi, Alberto; Frasheri, Arian; Garbo, Roberto; Masotti-Cento, Monica; Salvatella Giralt, Neus; Oteo Dominguez, Juan Francisco; Steffanon, Luigi; Presbitero, Patrizia; Pucci, Edoardo; Fraccaro, Chiara; Mauri, Josepa; Giustino, Gennaro; Sardella, Gennaro; Colombo, Antonio (Elsevier, 2016)

BACKGROUND/OBJECTIVES: The randomized SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy) trial showed the non-inferiority of 6 vs. 12-month DAPT after ...
Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion

Ribas Barquet, Núria; García-García, Cosme; Meroño, Oona; Recasens, Lluís; Pérez-Fernández, Silvia; Bazán, Víctor; Salvatella Giralt, Neus; Martí-Almor, Julio; Bruguera-Cortada, Jordi; Elosua Llanos, Roberto (BioMed Central, 2017)

Background: The AMI code is a regional network enhancing a rapid and widespread access to reperfusion therapy (giving priority to primary angioplasty) in patients with acute ST-segment elevation myocardial infarction ...

Now showing items 1-5 of 5

Search DSpace

Advanced Search

Browse

All of DSpace

My Account

Compliant to Partaking

Browsing by Author "Salvatella Giralt, Neus"

Browsing by Author "Salvatella Giralt, Neus"

Search DSpace

Browse

All of DSpace

My Account